Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Treasury Shares (2022 - 2025)

Historic Treasury Shares for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to $19.0.

  • Phathom Pharmaceuticals' Treasury Shares changed 0.0% to $19.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $19.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $19.0 for FY2024, which is 0.0% changed from last year.
  • Phathom Pharmaceuticals' Treasury Shares amounted to $19.0 in Q3 2025, which was down 0.0% from $19.0 recorded in Q2 2025.
  • Phathom Pharmaceuticals' 5-year Treasury Shares high stood at $922214.0 for Q1 2022, and its period low was $19.0 during Q1 2023.
  • Over the past 4 years, Phathom Pharmaceuticals' median Treasury Shares value was $19.0 (recorded in 2023), while the average stood at $168106.7.
  • As far as peak fluctuations go, Phathom Pharmaceuticals' Treasury Shares crashed by 9999.79% in 2023, and later changed by 0.0% in 2024.
  • Quarter analysis of 4 years shows Phathom Pharmaceuticals' Treasury Shares stood at $254437.0 in 2022, then tumbled by 99.99% to $19.0 in 2023, then changed by 0.0% to $19.0 in 2024, then changed by 0.0% to $19.0 in 2025.
  • Its Treasury Shares stands at $19.0 for Q3 2025, versus $19.0 for Q2 2025 and $19.0 for Q1 2025.